Previous studies have shown an increased risk of cardiovascular disease (CVD) in RA compared with the general population and patients with RA have a 60% increased risk of stroke (2), possibly higher in young and anti-citrullinated protein antibodies (ACPA) positive patients (3–5). This evidence concerns the gene PRTN3 and rheumatoid arthritis.